Aminoglycosides Flashcards

1
Q

What is the chemical structure of aminoglycosides?

A

Two or three sugars attached through glycosidic linkages to an aminocyclitol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the admixture incompatibilities?

A

Admixture with penicillins can cause precipitation (insoluble salt complex) and inactivation of both drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What aminoglycosides are most susceptible to admixture incompatibilities?

A
  • Gentamicin
  • Tobramycin
  • Amikacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What beta-lactam antibiotics are the most problematic in admixture incompatibilities?

A
  • Ticarcillan, Carbenicillin–no longer available
  • Piperacillin/tazobactam
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do you avoid admixture incompatibilities?

A

If giving two drugs, then administer into different tissue compartments (one drug on each arm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the MOA?

A

Inhibition of protein synthesis
* Binds to the bacterial 30S ribosomal unit which:
* Interferes with initiation of protein synthesis
* Blocks 30S-50S ribosomal complex from forming at the start codon of 16S mRNA
* Blocks further translation of the message
* Causes misreading of mRNA which leads to
* Production of nonfunctional proteins
* Incompletely synthesized protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the SOA of aminoglycosides?

A

Serious systemic infections due to gram-negative bacilli (rods) that can grow aerobically
* Strict aerobes
* Facultative aerobes
* Ex: Pseudomonas, enterobacterales

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is aminoglycosides less susceptible to?

A
  • Aerobic gram-positive cocci (synergism with beta-lactams for Enterococci)
  • Aerobic gram-negative cocci
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are aminoglycosides resistant to?

A
  • Anaerobes
  • Stentrophomonas
  • Burkholderia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are aminoglycosides pharmacodynamic properties?

A
  • Bactericidal
  • Rate and extent of killing is concentration dependent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Post antibiotic effect

A
  • Residual bactericidal activity persist after serum concentration has fallen below the MIC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the special patient populations with altered PK?

A
  • Burn patients
  • Critically ill
  • Obesity
  • CF
  • Ascites
  • Overhydration
  • Dialysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the pharmacokinetics?

A
  • Very poor oral bioavailability due to high polar cations
  • Wide to extracellular fluid (ECF)
  • Highly polar nature excludes many cells
  • Negligible protein binding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the elimination of aminoglycosides?

A
  • Almost entirely via glomerular filtration as unchanged drug
  • Do NOT require metabolism
  • Elimination rate increases in proportion with CrCl
  • Half-life: 2-3 hrs in patients with normal renal function (anephric patients: half-life is 20-40x that of those with normal renal function)
  • Regimen MUST be adjusted with impaired renal function (to avoid nephrotoxicity)
  • Pharmacokinetic/Therapeutic Drug Monitoring (TDM) is required
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nephrotoxicity

A
  • Toxicity due to accumulation and retention in the proximal renal tubular cells
  • Consequence = reduced excretion and additional risk of other toxicities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the two types of ototoxicity?

A
  • Cochlear
  • Vestibular
17
Q

What are the risks of getting cochlear ototoxicity?

A
  • Genetic predisposition
  • Preexisting hearing problems
  • Loop diuretics co-admin
18
Q

Vestibular ototoxicity

A
  • Manifest as vertigo or ataxia
  • Most common with streptomycin
19
Q

What are the risk factor of ototoxicity?

A
  • Frequent or very high doses
  • Very high blood levels of the drug
  • Long duration of therapy ( > 3 days)
  • Older age
20
Q

Neuromuscular toxicity

A
  • Rare
  • Prolongs neuromuscular blocker effect (typically with higher doses)
  • Can worsen weakness in disorders affecting neuromuscular transmission (ex: myasthenia gravis)
21
Q

What are some contraindications?

A
  • Pregnancy
  • Hypersensitivity
22
Q

When should aminoglycosides be used in caution in?

A
  • Vertigo
  • Tinnitus
  • Hearing loss
  • Renal disease
  • Neuromuscular disease
23
Q

What are some drug interactions?

A
  • Vancomycin (nephrotoxicity)
  • Loop diuretics (nephrotoxicity, ototoxicity)
  • Polypeptide antibiotics (nephrotoxicity, neuromuscular toxicity)
24
Q

Which aminoglycosides are used to treat Pseudomonas?

A
  • Tobramycin preferred for urinary tract
  • Amikacin for urinary infections
25
Which aminoglycoside is used to treat Enterobacterales?
Gentamicin
26
Which aminoglycoside is used to treat MDR organism?
Plazomicin
27
What is the 4 types of bacterial resistance?
* Bacterial enzymes modify the antibiotic--> prevents it from binding to the ribosome (**Aminoglycoside Modifying Enzymes**) * Production of 16S rRNA methyltransferase--> alteration of ribosomal target * Upregulation of efflux pumps--> decreased accumulation within the bacterium * Loss of outer membrane proteins--> reduced permeability into bacterial cells
28
Aminoglycosides Modifying Enzymes
Strains carrying R factors synthesize enzymes capable of reacting with amino or hydroxyl groups: * Aminoacetyltransferases (AAC)--> acetylation * Aminoglycoside acetyltransferase * Phosphotransferase (APH)--> phosphorylation * Aminoglycoside phosphotransferase * Nucleotidyltransferase (ANT)--> adenylation * Aminoglycoside nucleotidyltransferase